Poly Medicure Limited Statistics
Want to see IN:POLYMED full AI Analyst Report?
Poly Medicure Limited (POLYMED) Stock Statistics & Valuation Metrics
Total Valuation
Poly Medicure Limited has a market cap or net worth of INR 163.72B. The enterprise value is INR 166.42B.
- Market Cap
- INR 163.72B
- Enterprise Value
- INR 166.42B
Share Statistics
Poly Medicure Limited has 101,361,465 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 101,361,465
- Owned by Insiders
- ―
- Owned by Institutions
- 3.64%
Financial Efficiency
Poly Medicure Limited’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 6.74%.
- Return on Equity (ROE)
- 0.10
- Return on Assets (ROA)
- 0.08
- Return on Invested Capital (ROIC)
- 6.74%
- Return on Capital Employed (ROCE)
- 0.10
- Revenue Per Employee
- 7.17M
- Profits Per Employee
- 1.23M
- Employee Count
- 2,614
- Asset Turnover
- 0.48
- Inventory Turnover
- 2.57
Valuation Ratios
The current PE Ratio of Poly Medicure Limited is 53.26. Poly Medicure Limited’s PEG ratio is -4.49.
- PE Ratio
- 53.26
- PS Ratio
- 7.95
- PB Ratio
- 5.19
- Price to FCF
- -257.43
- Price to Operating Cash Flow
- 185.49
- PEG Ratio
- -4.49
Income Statement
In the last 12 months, Poly Medicure Limited had revenue of 18.75B and earned 3.22B in profits. Earnings per share was 31.79.
- Revenue
- 18.75B
- Gross Profit
- 7.61B
- Operating Income
- 3.27B
- Pretax Income
- 4.27B
- Net Income
- 3.22B
- EBITDA
- 5.61B
- Earnings Per Share (EPS)
- 31.79
Cash Flow
In the last 12 months, operating cash flow was 914.43M and capital expenditures -1.57B, giving a free cash flow of -658.89M billion.
- Operating Cash Flow
- 914.43M
- Free Cash Flow
- -658.89M
- Free Cash Flow per Share
- -6.50
Dividends & Yields
Poly Medicure Limited pays an annual dividend of INR 3.50, resulting in a dividend yield of 0.21%
- Dividend Per Share
- INR 3.50
- Dividend Yield
- 0.21%
- Payout Ratio
- 10.71%
- Free Cash Flow Yield
- -0.39%
- Earnings Yield
- 1.88%
Stock Price Statistics
- Beta
- 1.21
- 52-Week Price Change
- -19.02%
- 50-Day Moving Average
- 1627.95
- 200-Day Moving Average
- 1535.73
- Relative Strength Index (RSI)
- 64.84
- Average Volume (3m)
- 8,898
Important Dates
Poly Medicure Limited upcoming earnings date is Jan 22, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Jan 22, 2027
- Ex-Dividend Date
- Sep 18, 2025
Financial Position
Poly Medicure Limited as a current ratio of 3.37, with Debt / Equity ratio of 11.38%
- Current Ratio
- 3.37
- Quick Ratio
- 2.62
- Debt to Market Cap
- 0.03
- Net Debt to EBITDA
- 0.47
- Interest Coverage Ratio
- 17.87
Taxes
In the past 12 months, Poly Medicure Limited has paid 1.07B in taxes.
- Income Tax
- 1.07B
- Effective Tax Rate
- 0.25
Enterprise Valuation
Poly Medicure Limited EV to EBITDA ratio is 33.10, with an EV/FCF ratio of -262.80.
- EV to Sales
- 8.11
- EV to EBITDA
- 33.10
- EV to Free Cash Flow
- -262.80
- EV to Operating Cash Flow
- 189.36
Balance Sheet
Poly Medicure Limited has INR 8.27B in cash and marketable securities with INR 0.00 in debt, giving a net cash position of INR 8.27B billion.
- Cash & Marketable Securities
- INR 8.27B
- Total Debt
- INR 0.00
- Net Cash
- INR 8.27B
- Net Cash Per Share
- INR 81.59
- Tangible Book Value Per Share
- INR 310.70
Margins
Gross margin is 39.82%, with operating margin of 16.21%, and net profit margin of 14.92%.
- Gross Margin
- 39.82%
- Operating Margin
- 16.21%
- Pretax Margin
- 19.94%
- Net Profit Margin
- 14.92%
- EBITDA Margin
- 24.52%
- EBIT Margin
- 18.04%
Analyst Forecast
The average price target for Poly Medicure Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 24.64%
- EPS Growth Forecast
- -12.08%
Scores
- Smart Score
- ―
- AI Score
- 52
